Clinical Trial Update: Comparison Study of Insulin Glargine and NPH Insulin [Phase 4]

View source ↗

Summary

Phase 4 comparison trial of insulin glargine versus NPH insulin was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus

Drugs mentioned

• Insulin Glargine (insulin glargine)
• NPH insulin (insulin isophane)

Snippet

Sponsor: Providence Health & Services | Conditions: Diabetes | Phase 4 | Status: WITHDRAWN